Matrix Metalloproteinase 9
"Matrix Metalloproteinase 9" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An endopeptidase that is structurally similar to MATRIX METALLOPROTEINASE 2. It degrades GELATIN types I and V; COLLAGEN TYPE IV; and COLLAGEN TYPE V.
| Descriptor ID |
D020780
|
| MeSH Number(s) |
D08.811.277.656.300.480.205.360 D08.811.277.656.300.480.252.445 D08.811.277.656.300.480.525.700.350 D08.811.277.656.675.374.205.360 D08.811.277.656.675.374.252.445 D08.811.277.656.675.374.525.700.350 D12.644.276.848.350 D12.776.467.836.350
|
| Concept/Terms |
Matrix Metalloproteinase 9- Matrix Metalloproteinase 9
- Metalloproteinase 9, Matrix
- 92-kDa Type IV Collagenase
- 92 kDa Type IV Collagenase
- Matrix Metalloproteinase-9
- MMP9 Metalloproteinase
- Metalloproteinase, MMP9
- MMP-9 Metalloproteinase
- MMP 9 Metalloproteinase
- Metalloproteinase, MMP-9
- 92-kDa Gelatinase
- 92 kDa Gelatinase
- Gelatinase B
|
Below are MeSH descriptors whose meaning is more general than "Matrix Metalloproteinase 9".
Below are MeSH descriptors whose meaning is more specific than "Matrix Metalloproteinase 9".
This graph shows the total number of publications written about "Matrix Metalloproteinase 9" by people in this website by year, and whether "Matrix Metalloproteinase 9" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1999 | 1 | 3 | 4 |
| 2000 | 1 | 1 | 2 |
| 2001 | 3 | 2 | 5 |
| 2002 | 1 | 4 | 5 |
| 2003 | 1 | 1 | 2 |
| 2004 | 3 | 1 | 4 |
| 2005 | 2 | 2 | 4 |
| 2006 | 5 | 2 | 7 |
| 2007 | 1 | 1 | 2 |
| 2008 | 1 | 6 | 7 |
| 2009 | 1 | 2 | 3 |
| 2010 | 2 | 4 | 6 |
| 2011 | 4 | 4 | 8 |
| 2012 | 0 | 4 | 4 |
| 2014 | 0 | 4 | 4 |
| 2015 | 4 | 2 | 6 |
| 2016 | 3 | 2 | 5 |
| 2017 | 2 | 2 | 4 |
| 2018 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2020 | 1 | 3 | 4 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Matrix Metalloproteinase 9" by people in Profiles.
-
Differential Effects of Pancreatic Cancer-Derived Extracellular Vesicles Driving a Suppressive Environment. Int J Mol Sci. 2023 Sep 27; 24(19).
-
Susceptibility of Rat Steatotic Liver to Ischemia-Reperfusion Is Treatable With Liver-Selective Matrix Metalloproteinase Inhibition. Hepatology. 2020 11; 72(5):1771-1785.
-
miR-18a Inhibits BMP4 and HIF-1a Normalizing Brain Arteriovenous Malformations. Circ Res. 2020 10 09; 127(9):e210-e231.
-
Targeting the NLRP3 Inflammasome With Inhibitor MCC950 Prevents Aortic Aneurysms and Dissections in Mice. J Am Heart Assoc. 2020 04 07; 9(7):e014044.
-
Deletion of Fmr1 from Forebrain Excitatory Neurons Triggers Abnormal Cellular, EEG, and Behavioral Phenotypes in the Auditory Cortex of a Mouse Model of Fragile X Syndrome. Cereb Cortex. 2020 03 14; 30(3):969-988.
-
Lung Adenocarcinoma Syndecan-2 Potentiates Cell Invasiveness. Am J Respir Cell Mol Biol. 2019 06; 60(6):659-666.
-
Matrix metalloproteinase-9 deficiency protects mice from severe influenza A viral infection. JCI Insight. 2018 12 20; 3(24).
-
Genetic variants in the metzincin metallopeptidase family genes predict melanoma survival. Mol Carcinog. 2018 Jan; 57(1):22-31.
-
MyD88 contribution to ocular surface homeostasis. PLoS One. 2017; 12(8):e0182153.
-
Curcumin exhibits anti-tumor effect and attenuates cellular migration via Slit-2 mediated down-regulation of SDF-1 and CXCR4 in endometrial adenocarcinoma cells. J Nutr Biochem. 2017 06; 44:60-70.